Financial results - PHARMAZONE INNOVATIVE SRL

Financial Summary - Pharmazone Innovative Srl
Unique identification code: 18415094
Registration number: J2006003035407
Nace: 4690
Sales - Ron
576.695
Net Profit - Ron
100.291
Employees
2
Open Account
Company Pharmazone Innovative Srl with Fiscal Code 18415094 recorded a turnover of 2024 of 576.695, with a net profit of 100.291 and having an average number of employees of 2. The company operates in the field of Comerţ cu ridicata nespecializat having the NACE code 4690.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Pharmazone Innovative Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 66.588 - 155.390 294.823 350.784 400.611 470.965 583.374 574.975 576.695
Total Income - EUR 69.286 - 155.867 295.168 352.360 401.541 477.690 587.912 584.725 597.168
Total Expenses - EUR 71.526 - 113.451 211.888 288.891 327.103 373.232 462.891 449.872 480.041
Gross Profit/Loss - EUR -2.240 - 42.415 83.279 63.469 74.438 104.458 125.021 134.853 117.127
Net Profit/Loss - EUR -2.538 - 40.855 80.332 60.183 71.182 100.778 120.362 125.395 100.291
Employees 2 - 2 1 2 2 2 2 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 0.9%, from 574.975 euro in the year 2023, to 576.695 euro in 2024. The Net Profit decreased by -24.403 euro, from 125.395 euro in 2023, to 100.291 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Pharmazone Innovative Srl

Rating financiar

Financial Rating -
PHARMAZONE INNOVATIVE SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Pharmazone Innovative Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Pharmazone Innovative Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Pharmazone Innovative Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Pharmazone Innovative Srl - CUI 18415094

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 52.576 - 43.753 2.310 30.437 31.990 20.132 9.559 2.347 2.986
Current Assets 29.666 - 41.122 197.627 124.328 171.384 237.215 289.013 294.259 307.530
Inventories 11.883 - 13.091 59.116 54.111 61.904 113.570 132.917 141.485 203.708
Receivables 12.727 - 19.315 93.313 30.342 55.275 28.046 44.008 45.844 37.845
Cash 5.056 - 8.715 45.197 39.875 54.205 95.598 112.088 106.929 65.976
Shareholders Funds -24.382 - 6.808 69.315 69.248 106.475 162.335 187.148 202.104 209.490
Social Capital 450 - 438 430 421 413 404 406 404 402
Debts 106.693 - 78.097 130.717 85.986 97.679 95.677 112.531 95.256 101.821
Income in Advance 0 - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4690 - 4690"
CAEN Financial Year 4690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 307.530 euro in 2024 which includes Inventories of 203.708 euro, Receivables of 37.845 euro and cash availability of 65.976 euro.
The company's Equity was valued at 209.490 euro, while total Liabilities amounted to 101.821 euro. Equity increased by 8.515 euro, from 202.104 euro in 2023, to 209.490 in 2024.

Risk Reports Prices

Reviews - Pharmazone Innovative Srl

Comments - Pharmazone Innovative Srl

Comments can only be added from a RisCo client account. Login
See Comments

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.